Seven Editora
##common.pageHeaderLogo.altText##
##common.pageHeaderLogo.altText##

Contact

  • Seven Publicações Ltda CNPJ: 43.789.355/0001-14 Rua: Travessa Aristides Moleta, 290- São José dos Pinhais/PR CEP: 83045-090
  • Principal Contact
  • Nathan Albano Valente
  • (41) 9 8836-2677
  • editora@sevenevents.com.br
  • Support Contact
  • contato@sevenevents.com.br

Systematic review on the relationship between the use of oral contraceptives and Vulvovaginal Atrophy (VVA): Effects, symptoms and implications on the quality of life of patients

  • 29/08/2023
  • 29/08/2023
Moliterno A;
Piccoli MVF

Amanda Moliterno

Maria Victoria Ferreira Piccoli

Keywords

Vulvovaginal atrophy
AVV

Abstract

Vulvovaginal atrophy (AVV) is a frequent condition in the postmenopausal period and has been associated with the use of oral contraceptives due to the disruptions in hormone levels that these medications can cause. However, the amount of data available on this relationship is limited due to underreporting of cases.

 

DOI:https://doi.org/10.56238/uniknowindevolp-015

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2023 Amanda Moliterno, Maria Victoria Ferreira Piccoli
Chapter 15
Certificate

Author(s)

  • Amanda Moliterno
  • Maria Victoria Ferreira Piccoli